Catalyst Wire Dossier Catalyst Wire Dossier

Magnevist

gadopentetate dimeglumine · Bayer HealthCare
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Magnevist, covering 2010-07-15 to 2017-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases [NA]

See pricing